Physician profile
Caleb Cooper
NPI 1871086264
$3,366.06
in general payments reported to CMS, 2019-2025
7 companies · $2,132 in 2025
The $2,132 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $75.89 · 2021: $188 · 2022: $271 · 2024: $700 · 2025: $2,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,529 · Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,529.22 |
| Food and Beverage | $1,302.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,045.36 | 2020-2025 | Axonics, Ams 700, Rezum Generator |
| Olympus Corporation of The Americas | $606.04 | 2025 | Uretero-Reno Fiberscope, Uropass, Gyrus Acmi |
| Procept Biorobotics Corporation | $480.73 | 2024 | Aquabeam System |
| Laborie Medical Technologies Corp. | $56.21 | 2025 | |
| Olympus America INC. | $36.76 | 2025 | Itind System |
| Hologic Sales and Service, LLC | $29.65 | 2024 | Omni Hysteroscope, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $23.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.